Short Implants Produced by Additive Manufacturing in the Posterior Jaws: 3 Years of Follow-up

Condition(s) studied

Investigational drug(s) / intervention(s)

diagonstic: The aim of the study will be to evaluate the bone loss and peri-implant complications of short implants produced by additive manufacturing

Study summary

Implant-supported rehabilitation of regions with severe bone resorption is a challenge for implant dentists. Structures such as the maxillary sinus and the inferior alveolar canal often make it impossible to use implants of lengths considered standard in the literature. The use of short implants produced by additive manufacturing (AM) provides a new surface, promoting osseointegration and reducing problems such as peri-implantitis. However, longitudinal evaluations of implants produced by AM are still scarce in the literature. A total of 100 subjects rehabilitated with short implants produced by MA, with diameters between 4.0 to 6.0 mm and 5 to 7 mm in length, will be evaluated. Peri-implant bone remodeling, as well as clinical parameters, will be evaluated by implant and throughout the evaluation time. Periapical radiographs will be obtained and scanned, analyzed by software, and compared to baseline data. The data obtained will be analyzed, allowing longitudinal evaluations and the success rate of implant restorations supported by short implants.

Eligibility

Primary outcome measure(s)

• The primary outcome variable of the study will be variation in bone remodeling between the initial and final values (measured in mm) — 36 months
  Bone loss measured from the abutment-implant junction to the first visible bone to implant contact visible in a X-ray

Trial sites (1)

More University of Guarulhos trials in Brazil

Other trials for the same condition